Kartal Training and Research Hospital, Kartal, Turkey.
J Cancer Res Clin Oncol. 2011 Sep;137(9):1371-7. doi: 10.1007/s00432-011-1007-z. Epub 2011 Jul 26.
The aim of this study was to investigate the relation between Cathepsin D (Cath-D) and E-Cadherin (E-Cad) expression levels in tumor tissue and neck lymph node metastasis. This attempt should be made to identify new factors that one could be useful in predicting clinical behavior.
In this study, we investigated rates of dying for E-Cad and Cath-D in paraphin blocks of larynx and neck dissection specimens taken from 56 selected patients. Laryngeal specimens dyed by ECad and Cath-D immunohistochemically. Immunoreactivity classified for E-Cad as positive (75% and above), reduced (25-75%) and negative (below 25%). Immunoreactivity classified for Cath-D:dye absorption rates higher than 50% evaluated positive and absorption rates lower than 50% evaluated negative. We compared the rates of dying for E-Cad and Cath-D groups to with or without neck lymph node metastasis in specimens.
Neck metastasis were found in 41% of patients, in 55.6% of patients, if the E-Cad was negative, 40.6% if it was reduced, 33.3% if it was positive in specimens. The neck metastasis was found in 35.4% of patients with Cath-D expression negative, while 75% of patients was found with Cath-D expression positive.
Neck metastasis was found higher in E-Cad reduced group than positive group. Neck node metastasis was significantly higher in Cath-D positive group than Cath-D negative group. Cath-D and E-Cad essays may useful in identifying neck lymph node involvement. Cath-D expression levels are more in this predictive factor than E-Cad levels for possibility of neck lymph node metastasis in LSCC.
本研究旨在探讨肿瘤组织中组织蛋白酶 D(Cath-D)和 E-钙黏蛋白(E-Cad)表达水平与颈部淋巴结转移的关系。试图确定新的因素,这些因素可能有助于预测临床行为。
在这项研究中,我们调查了 56 名选定患者的喉和颈部淋巴结清扫标本中的石蜡块中 E-Cad 和 Cath-D 的死亡率。用 ECad 和 Cath-D 免疫组织化学对喉标本进行染色。E-Cad 的免疫反应性分类为阳性(75%及以上)、降低(25-75%)和阴性(低于 25%)。Cath-D 的免疫反应性分类:吸收率高于 50%评估为阳性,吸收率低于 50%评估为阴性。我们比较了标本中有无颈部淋巴结转移的 E-Cad 和 Cath-D 组的死亡率。
41%的患者发生颈部转移,如果 E-Cad 阴性,55.6%的患者发生颈部转移,降低为 40.6%,阳性为 33.3%。Cath-D 表达阴性的患者中有 35.4%发生颈部转移,而 Cath-D 表达阳性的患者中有 75%发生颈部转移。
E-Cad 降低组的颈部转移率高于阳性组。Cath-D 阳性组的颈部淋巴结转移率明显高于 Cath-D 阴性组。Cath-D 和 E-Cad 检测可能有助于识别颈部淋巴结受累。在 LSCC 中,Cath-D 表达水平比 E-Cad 水平更能预测颈部淋巴结转移的可能性。